Quick Takeaways
- Versant Venture Capital VI, L.P. filed SCHEDULE 13D/A for Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST).
- Disclosed ownership: 1.1%.
- Date of event: 30 Mar 2026.
Versant Venture Capital VI, L.P. - 30 Mar 2026 SCHEDULE 13D/A Report for Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST)
- Filing Manager
- Versant Venture Capital VI, L.P.
- Reporting Manager
- Versant Vantage II, L.P.
- Symbol
- TPST
- Shares outstanding
- 14,815,636 shares
- Disclosed Ownership
- 162,972 shares
- Ownership
- 1.1%
- Form type
- SCHEDULE 13D/A
- Filing time
- 02 Apr 2026, 16:30:29 UTC
- Date of event
- 30 Mar 2026
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Versant Venture Capital VI, L.P. disclosed 1.1% ownership in Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST) on 30 Mar 2026."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 02 Apr 2026, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P. | 0.1% | 16,149 | 16,149 | 0 | /s/Max Eisenberg | Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the general partner of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P. | 0001687880 |
| Versant Ventures VI GP, L.P. | 0.1% | 16,149 | 0 | 16,149 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer of Versant Ventures VI GP-GP, LLC, the general partner of Versant Ventures VI GP, L.P. | 0001777654 |
| Versant Ventures VI GP-GP, LLC | 0.1% | 16,149 | 0 | 16,149 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer | 0001777652 |
| Versant Vantage II, L.P. | 1.1% | 162,972 | 162,972 | 0 | /s/Max Eisenberg | Max Eisenberg/COO of Versant Vantage II GP-GP, LLC, the general partner of Versant Vantage II GP, L.P., the GP of Versant Vantage II, L.P. | 0001832235 |
| Versant Vantage II GP, L.P. | 1.1% | 162,972 | 0 | 162,972 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer of Versant Vantage II GP-GP, LLC, the general partner of Versant Vantage II GP, L.P. | 0001839790 |
| Versant Vantage II GP-GP, LLC | 1.1% | 162,972 | 0 | 162,972 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer | 0001839789 |
| Versant Venture Capital IV, L.P. | 0.6% | 90,084 | 90,084 | 0 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer of Versant Ventures IV, LLC, the general partner of Versant Venture Capital IV, L.P. | 0001456590 |
| Versant Side Fund IV, L.P. | 0% | 567 | 567 | 0 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer of Versant Ventures IV, LLC, the general partner of Versant Side Fund IV, L.P. | 0001456591 |
| Versant Ventures IV, LLC | 0.6% | 90,651 | 0 | 90,651 | /s/Max Eisenberg | Max Eisenberg/Chief Operating Officer | 0001456589 |